Thomas Burns

CEO
Glaukos

Thomas Burns

CEO
Glaukos

Bio

Mr. Burns has provided the leadership for Glaukos since its founding in 2001 to create the premier device franchise in glaucoma treatment– a business that was recently ranked #19 by the Wall Street Journal in a review of over 5000 venture-backed companies. He has built substantial value, delivered rapid growth and created entirely new commercial product classes and global markets in senior leadership roles at three major, successful start-up companies.

Prior to Glaukos, Mr. Burns led Eyetech (acquired by OSI Pharmaceuticals, Inc.) as President & COO, Director and raised $108M in a final private placement round to prepare the business for a successful $157M initial public offering. At Chiron Vision, Mr. Burns served as Sr. Vice President and GM, to build that business from a start-up in 1990 to a successful $310 million acquisition by Bausch & Lomb in 1998. Mr. Burns has served as an Entrepreneur-in-Residence at Versant Ventures, a distinguished health-care venture capital firm. As a leading serial entrepreneur, Mr. Burns has raised a quarter billion dollars to date in private placements to build successful businesses. Mr. Burns received his bachelor’s degree in history from Yale University.

All sessions by Thomas Burns